|
Joinn Laboratories (China) Co., Ltd. is a non-clinical contract research organization (CRO) specializing in drug safety assessment. Founded in 1995, the company provides pharmacology and toxicology evaluation services for drugs, adhering to international standards such as FDA and ICH guidelines. Its core business includes non-clinical studies, clinical trial services, and research model businesses, with facilities in Beijing and Suzhou that hold OECD GLP certification. The company serves pharmaceutical clients in China, the United States, and other regions, offering regulatory-compliant evaluation reports to agencies including the NMPA and FDA. Key subsidiaries include JOINN (Beijing) Biotechnology Ltd. and JOINN Clinical (Suzhou) Co., Ltd. Summarised from the company's own disclosures, fiscal year ended Apr 2026 |
Industry Diagnostics & Research | Homepage joinnlabs.com |
| Sector Healthcare | IR page joinnlabs.com/investor.php | |
|
Tags
non-clinical cro, drug safety assessment, pharmacology, toxicology, glp compliance, clinical trial services, research models, pharmaceutical r&d, JOINN (Beijing) Biotechnology Ltd., JOINN Clinical (Suzhou) Co. Ltd.
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | HK$ 12.152B |
| Market cap (USD) | $ 1.549B |
| P/E | 43.10 |
| PEG | — |
| P/BV | 1.15 |
| P/S | 6.10 |
| P/OCF | 13.99 |
| P/FCF | — |
| Dividend yield | 0.72% |
| Turnover / mcap | 0.60% |
| Returns | |
|---|---|
| ROE | 3.6% |
| ROI | 3.6% |
| ROIC | 4.1% |
| Profit margin | 18.0% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | -34.8% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | -29.4% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpAnnouncements and reports published on HKEXnews, newest first, monthly and next-day returns, proxy forms and board-meeting notices included. The link opens the announcement on HKEXnews. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Joinn Laboratories (China) Co., Ltd.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| AVEE | 0.03% | 12,500 | $ 35.047K | Nov 16, 2026 |
| AVSE | 0.01% | 6,500 | $ 18.225K | Nov 16, 2026 |
| DFEM | 0.00% | 105,300 | $ 327.525K | Nov 12, 2026 |
| DFSE | 0.00% | 5,700 | $ 17.729K | Nov 12, 2026 |
| DFAX | 0.00% | 43,700 | $ 135.924K | Nov 12, 2026 |
| DFAE | 0.00% | 26,700 | $ 83.048K | Nov 12, 2026 |
| AVEM | 0.00% | 412,600 | $ 1.157M | Nov 16, 2026 |







